Accent Microcell Ltd

AI

Accent Microcell Ltd

₹
- close price
About

Incorporated in 2012, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]

Key Points

Business Overview:[1]
AMC is an EXCiPACT, US-DMF, GMP, ISO 9001:2008, HACCP certified manufacturer and exporter of 22 different grades of Microcrystalline Cellulose (MCC). It caters to 10+ sectors and services 200+ customers in India and worldwide.

  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE %
  • ROE %
  • Face Value ₹

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2023 (S) Mar 2024 (S) Sep 2024 (S) Mar 2025 (S) Sep 2025 (S) Mar 2026 (S) Sep 2026 (S)
107 139 126 139 139 210 175
87 119 107 115 115 177 134
Operating Profit 20 20 19 23 24 33 41
OPM % 18% 14% 15% 17% 17% 16% 24%
1 2 3 3 3 4 3
Interest 1 0 0 0 0 0 0
Depreciation 2 2 2 2 2 3 2
Profit before tax 17 19 20 24 24 34 41
Tax % 18% 17% 16% 32% 25% 25% 25%
14 16 16 17 18 26 31
EPS in Rs 8.65 7.24 7.42 7.48 7.53 10.75 12.97
Raw PDF

(S): Standalone figures, shown where consolidated figures are not available.

Profit & Loss

Figures in Rs. Crores

Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
114 131 133 166 197 246 265 349
108 122 122 153 178 206 223 292
Operating Profit 6 9 11 13 19 39 42 57
OPM % 4.9% 7% 8% 8% 10% 16% 16% 16%
6 4 2 2 2 3 6 7
Interest 3 3 3 3 3 1 0 1
Depreciation 3 3 4 4 4 4 4 5
Profit before tax 5 6 6 8 15 37 44 58
Tax % 24% 31% 20% 22% 17% 17% 24% 25%
4 4 5 6 12 30 33 44
EPS in Rs 2.22 2.56 2.94 3.61 7.50 13.59 14.89 18.28
Dividend Payout % 0% 0% 9% 18% 8% 7% 6% 5%

(S): Standalone figures, shown where consolidated figures are not available.

Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S) Sep 2026 (S)
Equity Capital 4 4 4 13 13 21 21 24 24
Reserves 17 21 22 19 37 143 174 252 280
32 30 31 24 23 13 2 1 1
20 22 23 38 37 28 32 45 41
Total Liabilities 73 77 81 95 111 205 228 322 346
30 29 30 30 31 29 48 53 56
CWIP 0 0 0 0 0 2 13 102 135
Investments 0 0 0 0 0 0 0 0 0
43 48 50 64 79 174 168 167 155
Total Assets 73 77 81 95 111 205 228 322 346

(S): Standalone figures, shown where consolidated figures are not available.

Cash Flows

Figures in Rs. Crores

Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
6 5 5 15 8 11 25 19
-4 -2 -6 -4 -4 -82 -9 -49
-1 -2 -2 -10 -4 72 -14 36
Net Cash Flow 1 1 -3 1 -1 1 2 6
Free Cash Flow 2 3 -0 11 3 -2 -12 -68
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 120% 72% 57% 127% 53% 44% 85% 56%

(S): Standalone figures, shown where consolidated figures are not available.

Ratios

Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Debtor Days 70 60 35 38 56 80 89 95
Inventory Days 67 78 128 128 128 83 76 55
Days Payable 89 80 74 97 106 48 42 33
Cash Conversion Cycle 48 58 88 68 79 114 124 117
Working Capital Days 19 30 37 16 41 79 101 95
ROCE % 18% 17% 19% 27% 31% 24% 25%

(S): Standalone figures, shown where consolidated figures are not available.

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Capacity Utilization - Dahej (SEZ) Unit II
% ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Capacity Utilization - Pirana Unit I
% ・Standalone data
Export Revenue Mix
% of TOI ・Standalone data
Total Installed Capacity
MTPA ・Standalone data
Top 10 Customer Concentration
% of TOI ・Standalone data
Premium Product Revenue Mix
% of Revenue ・Standalone data
Total Sales Volume
MT ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
55.09% 55.09% 55.09% 55.09% 55.44% 55.44% 55.47% 53.02% 51.40%
0.03% 0.02% 0.01% 0.01% 0.00% 0.29% 0.58% 0.91% 0.72%
1.62% 1.66% 2.19% 2.88% 3.29% 3.57% 3.59% 3.54% 2.43%
43.26% 43.23% 42.70% 42.01% 41.27% 40.70% 40.36% 42.53% 45.46%
No. of Shareholders 2,4182,9992,8342,9823,0613,0763,0543,1783,371

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents